Injectable nanoparticle siRNA conjugate mediated gene silencing for glioblastoma stem cells and tumor cells

dc.contributor.guideManzoor Koyakutty
dc.coverage.spatial
dc.creator.researcherManju C Abraham
dc.date.accessioned2023-01-10T07:11:37Z
dc.date.available2023-01-10T07:11:37Z
dc.date.awarded2022
dc.date.completed2022
dc.date.registered2013
dc.description.abstractNanoparticle based siRNA conjugate is a promising therapeutic approach as indicated by recent FDA approval. In this thesis, we have investigated the development and in vitro / in vivo characterization of multiple siRNA-loaded self-assembled nanoparticle gel (NPG) that can be injected locally into the brain (tumor resected cavity); for combinatorial silencing of genes associated with glioma stem cells (GSC). GSCs are characterized by deregulated stem-cell signaling, efficient drug-efflux properties, and the ability to scavenge reactive oxygen species. We used a clinically approved cationic peptide to orchestrate the self-assembly of multiple siRNA sequences targeting FAK, NOTCH-1, and SOX-2 into a single nanoparticle (n-siRNAFAK+NOTCH-1+SOX-2), which is further made into a locally injectable-gel using hyaluronic acid. The nanoparticles showed an average size of ~ 250 nm with ~ 95% siRNA loading efficiency and ~ 95.5% cellular uptake in GSCs characterized by CD133, Nestin, SOX-2, and NOTCH-1 expression. Silencing of FAK, NOTCH-1 or SOX-2 with their respective singular n-siRNA sequence resulted in down-regulation of specific targets but caused compensatory up-regulation of others. Upon simultaneous gene-silencing using n-siRNAFAK+NOTCH-1+SOX-2, ~ 90% GSCs underwent cell death and lost their ability to form GBM neurospheres, whereas normal stem cells remained unaffected while retaining neuronal differentiation capacity. GSCs derived from glioblastoma patients (n=4) showed inability to form neurospheres post nanoparticle treatment whereas the clinical drug; temozolomide, had little effect, indicating the clinical significance of NPG-based treatment. GBM patient derived xenograft (PDX) models exhibiting the characteristics of patient samples also showed significant impairment in the tumorigenic potential of nanoparticle-treated GSCs. In effect, this thesis investigation shows that locally injectable n-siRNA NPG targeted to multiple stem-cell signaling can impair the glioma initiation capabilities of GSCs. newline
dc.description.note
dc.format.accompanyingmaterialNone
dc.format.dimensions
dc.format.extentXIII, 87
dc.identifier.urihttp://hdl.handle.net/10603/440681
dc.languageEnglish
dc.publisher.institutionAmrita Centre for Nanosciences and Molecular Medicine
dc.publisher.placeCoimbatore
dc.publisher.universityAmrita Vishwa Vidyapeetham University
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordClinical Medicine
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordOncology tumor; Glioblastoma multiforme;GBM; siRNA;Silencing RNA;
dc.titleInjectable nanoparticle siRNA conjugate mediated gene silencing for glioblastoma stem cells and tumor cells
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 11
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
36 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_prelim pages.pdf
Size:
443.52 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_content.pdf
Size:
81.66 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_abstract.pdf
Size:
27.35 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_chapter 1.pdf
Size:
448.64 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: